• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌:从 Gleason 评分到预后分级分组

Prostate cancer: from Gleason scoring to prognostic grade grouping.

作者信息

Montironi Rodolfo, Santoni Matteo, Mazzucchelli Roberta, Burattini Luciano, Berardi Rossana, Galosi Andrea B, Cheng Liang, Lopez-Beltran Antonio, Briganti Alberto, Montorsi Francesco, Scarpelli Marina

机构信息

a Section of Pathological Anatomy , Polytechnic University of the Marche Region, School of Medicine, United Hospitals , Ancona , Italy.

b Clinica di Oncologia Medica, AOU Ospedali Riuniti , Polytechnic University of the Marche Region , Ancona , Italy.

出版信息

Expert Rev Anticancer Ther. 2016;16(4):433-40. doi: 10.1586/14737140.2016.1160780.

DOI:10.1586/14737140.2016.1160780
PMID:27008205
Abstract

The Gleason grading system was developed in the late 1960s by Dr. Donald F. Gleason. Due to changes in prostatic adenocarcinoma (PAC) detection and treatment, newer technologies to better characterize prostatic pathology, subsequently described variants of PAC and further data relating various morphologic patterns to prognosis, the application of the Gleason grading system changed substantially in surgical pathology. First in 2005 and more recently in 2014, consensus conferences were held to update PAC grading. Here, we review of the successive changes in the grading of PAC from the original system, with emphasis on the newest prognostic grade grouping.

摘要

格里森分级系统是由唐纳德·F·格里森博士在20世纪60年代末开发的。由于前列腺腺癌(PAC)检测和治疗的变化、用于更好地描述前列腺病理特征的新技术、随后描述的PAC变体以及将各种形态学模式与预后相关联的更多数据,格里森分级系统在外科病理学中的应用发生了重大变化。2005年首次以及最近在2014年,召开了共识会议以更新PAC分级。在此,我们回顾PAC分级从原始系统开始的连续变化,重点关注最新的预后分级分组。

相似文献

1
Prostate cancer: from Gleason scoring to prognostic grade grouping.前列腺癌:从 Gleason 评分到预后分级分组
Expert Rev Anticancer Ther. 2016;16(4):433-40. doi: 10.1586/14737140.2016.1160780.
2
International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.国际泌尿病理学会(ISUP)前列腺癌分级——当代分级的ISUP共识
APMIS. 2016 Jun;124(6):433-5. doi: 10.1111/apm.12533.
3
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.SOCS3免疫组化表达似乎支持2005年和2014年国际泌尿病理学会(ISUP)改良的Gleason分级系统。
Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1.
4
Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.在格里森(Gleason)和国际泌尿病理学会(ISUP)前列腺癌分级中存在争议的问题:国际实施的建议。
Pathology. 2019 Aug;51(5):463-473. doi: 10.1016/j.pathol.2019.05.001. Epub 2019 Jul 3.
5
From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.从前列腺癌的格里森分级到国际泌尿病理学会(ISUP)分级
Scand J Urol. 2016 Oct;50(5):325-9. doi: 10.1080/21681805.2016.1201858. Epub 2016 Jul 14.
6
Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.具有筛状结构和肾小球样特征的前列腺癌腺管应被视为 Gleason 4 级而非 3 级。
Future Oncol. 2016 Jun;12(12):1431-3. doi: 10.2217/fon-2016-0113. Epub 2016 Mar 30.
7
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.利用TROG 03.04“雷达”试验临床数据对细针穿刺活检中前列腺腺癌的国际泌尿病理学会(ISUP)分级进行验证。
Pathology. 2015 Oct;47(6):520-5. doi: 10.1097/PAT.0000000000000318.
8
Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.当代前列腺癌的Gleason分级:结合对实施2014年国际泌尿病理学会(ISUP)前列腺癌Gleason分级共识会议实际问题的讨论进行更新
Am J Surg Pathol. 2017 Apr;41(4):e1-e7. doi: 10.1097/PAS.0000000000000820.
9
Implications of the International Society of Urological Pathology modified Gleason grading system.国际泌尿病理学会改良 Gleason 分级系统的意义。
Arch Pathol Lab Med. 2012 Apr;136(4):426-34. doi: 10.5858/arpa.2011-0495-RA.
10
The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer.2014年国际泌尿病理学会(ISUP)前列腺癌分级系统的预后意义。
Pathology. 2015 Oct;47(6):515-9. doi: 10.1097/PAT.0000000000000315.

引用本文的文献

1
Exploring the metastatic potential of isolated tumour cells and clusters-cords patterns of ISUP Grade 5 acinar adenocarcinoma of the prostate: a comprehensive morphological analysis.探索前列腺ISUP 5级腺泡腺癌中分离出的肿瘤细胞的转移潜能及簇状-条索状模式:一项全面的形态学分析。
Virchows Arch. 2025 Sep 4. doi: 10.1007/s00428-025-04253-9.
2
Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI.探讨多模态特征提取的功效,结合放射组学和深度学习特征,用于基于 mpMRI 的前列腺癌分级。
BMC Med Imaging. 2023 Nov 22;23(1):195. doi: 10.1186/s12880-023-01140-0.
3
Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer.
靶向P21激活激酶-1治疗转移性前列腺癌。
Cancers (Basel). 2023 Apr 11;15(8):2236. doi: 10.3390/cancers15082236.
4
A Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into "Low-" and "High-Risk" Categories for Prostate Cancer.一种多变量模型中血清标志物的新型组合,用于帮助将前列腺癌患者分类为“低风险”和“高风险”类别。
Front Oncol. 2022 May 19;12:837127. doi: 10.3389/fonc.2022.837127. eCollection 2022.
5
The role of prostate-specific antigen density and negative multiparametric magnetic resonance imaging in excluding prostate cancer for biopsy-naïve men: clinical outcomes from a high-volume center in China.前列腺特异性抗原密度和阴性多参数磁共振成像在排除前列腺癌中的作用:来自中国一家高容量中心的临床结果。
Asian J Androl. 2022 Nov-Dec;24(6):615-619. doi: 10.4103/aja202220.
6
TRUS-Guided Target Biopsy for a PI-RADS 3-5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis.经直肠超声引导下对PI-RADS 3-5类索引病变进行靶向活检以减少Gleason评分低估:一项倾向评分匹配分析
Front Oncol. 2022 Jan 24;11:824204. doi: 10.3389/fonc.2021.824204. eCollection 2021.
7
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation.2021年前列腺癌:预后和治疗生物标志物评估的新进展
Cancers (Basel). 2021 Jul 11;13(14):3471. doi: 10.3390/cancers13143471.
8
Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?前列腺癌分级系统的叙述性综述:Gleason评分会被分级组取代吗?
Transl Androl Urol. 2021 Mar;10(3):1530-1540. doi: 10.21037/tau-20-853.
9
Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers.肥胖在泌尿生殖系统肿瘤中的关键作用,重点关注尿路上皮癌和前列腺癌。
Cancers (Basel). 2019 Aug 22;11(9):1225. doi: 10.3390/cancers11091225.
10
PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer.PITX2甲基化:一种用于监测前列腺癌生化复发风险的新型有效生物标志物。
Medicine (Baltimore). 2019 Jan;98(1):e13820. doi: 10.1097/MD.0000000000013820.